Skip to content

Prevalence of Undiagnosed Chronic Obstructive Pulmonary Disease Sufferers in the Region of Murcia

Prevalence of Undiagnosed Sufferers in Murcia :Cross-sectional Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01380470
Enrollment
1052
Registered
2011-06-27
Start date
2010-02-28
Completion date
2010-06-30
Last updated
2017-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

Chronic Obstructive Pulmonary Disease, Diagnosis differential, Dyspnea/classification, Dyspnea/etiology

Brief summary

The purpose of this study is determine the prevalence of undiagnosed Chronic Obstructive Pulmonary Disease (COPD) in population served and with exposure to cigarettes in the Region of Murcia

Detailed description

COPD is a serious, chronic and very disabling, associated with smoking and aging. Therefore it is a preventable and treatable process. It is know to be a pathology under diagnosed and when diagnosis, this is done in advanced stage, resulting to rise to more complication and more severe, in a addition to a high social and economic cost. Therefore, take out an epidemiological study, observational, multicentre, whose main objective is estimate the prevalence of undiagnosed COPD in population served between 40 and 70 years and exposure to cigarettes in the Region of Murcia. Other objectives are estimate the proportion of patients already diagnosed, identifying risk factors associated with not previous diagnosis of COPD and describe the history of symptoms in them. Description of therapeutic manage and motivation to give up smoking. The study was carried out with 120 researcher doctors and 120 researcher nurses from 40 health centers in the Region of Murcia. Each researcher will select 10 patients for the main objective and 10 for objectives related to manage of COPD.

Interventions

None listed

Sponsors

MurciaSalud
CollaboratorOTHER_GOV
Public Health Service, Murcia
CollaboratorOTHER
AstraZeneca
CollaboratorINDUSTRY
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

1. Aged between 40 and 70 years of both sexes 2. With a history of smoking (current or past) 3. Do not diagnosed with COPD at the time of completion of study

Exclusion criteria

1. Prior diagnosis of COPD or Asthma 2. A condition prevents performing spirometry 3. Patients displaced For those diagnosed with COPD: Inclusion Criteria: * Subject treated in CS there is explicit evidence for the disease

Design outcomes

Primary

MeasureTime frame
FEV1/FVC,Forced Expiratory Volume 1/ Forced Vital Capacity15 days

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026